Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERIXa Study
NCT05801068Completed
- Sponsor
- Seoul National University Hospital
- Start
- Aug 2020
- Primary completion
- May 2024
- Countries
- 1
01
Overview
Open-label, single-arm trial in Atrial fibrillation (AFib), sponsored by Seoul National University Hospital. Primary endpoint: 30-day major bleeding. Started Aug 2020; status: completed.
02
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT05801068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05801068.